Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Director comp.
Director departure
Appointed director
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "NeuroOne Medical Technologies Corporation Condensed Balance Sheets June 30, 2023 September 30, 2022 Assets Current assets: Cash and cash equivalents $ 3,083,458 $ 8,160,329 Short-term investments — 2,981,010 Accounts receivable — 33,237 Inventory 1,516,527 704,538 Prepaids and other 278,786 296,649 Total current assets 4,878,771 12,175,763 Intangible assets, net 95,156 111,892 Right-of-use asset 197,324 181,355 Property and equipment, net 586,873 353,599 Total assets $ 5,758,124 $ 12,822,609 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 958,811 $ 927,662 Accrued expenses and other liabilities 789,097 715,839 Deferred revenue — 1,455,188 Total current liabilities 1,747,908 3,098,689 Operating lease liability, long term 88,918 119,556 Total liabilities 1,836,82..."
05/11/2023 8-K Quarterly results
Docs: "NeuroOne Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update EDEN PRAIRIE, Minn., May 11, 2023 -- NeuroOne Medical Technologies Corporation , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the fiscal second quarter 2023 ended March 31, 2023. Fiscal Second Quarter 2023 and Recent Business Updates Evo sEEG: ● Announced the commercial launch of the Evo sEEG electrode product line in the United States with exclusive distribution partner Zimmer Biomet. The new technology potentially provides NeuroOne with a new revenue stream. ● The first clinical case using the Evo sEEG electrode was performed at the Mayo Clinic usin..."
12/22/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
02/14/2022 8-K Quarterly results
Docs: "NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update EDEN PRAIRIE, Minn., February 14, 2022 -- NeuroOne Medical Technologies Corporation , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces its operating results for the first quarter of fiscal year 2022 ended December 31, 2021. First Quarter and Recent Business Updates"
12/15/2021 8-K Quarterly results
08/13/2021 8-K Quarterly results
08/14/2019 8-K Quarterly results
Docs: "NeuroOne Medical Technologies Corporation Announces Fiscal Third Quarter 2019 Financial Results and Provides a Corporate Update Minnetonka, MN – August 14, 2019 – NeuroOne Medical Technologies Corporation , a medical device company focused on the development and commercialization of thin film electrode technology for recording brain activity, stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, and back pain, today announced its financial results for its fiscal third quarter ended June 30, 2019 and provided a corporate update. “We are very pleased with the progress we have made this quarter,” stated Dave Rosa, president and CEO of NeuroOne. “As disclosed earlier this year, we submitted a premarket notification 510 through a third-party United States..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy